MKI67 and neoplasm: Subsequently, the antitumor activity of RBC‐Nanovaccines combined with anti‐PD‐1 was analyzed by hematoxylin and eosin (H&E), Ki67, and TUNEL staining of tumor slices, demonstrating that the combination therapy had an excellent antitumor effect (Fig EV5A).